Skip to content

Prediction of Outcomes Following Total Knee Replacement- Pilot

Prediction of Outcomes Following Total Knee Replacement- Pilot

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04328701
Acronym
POKR-p
Enrollment
44
Registered
2020-03-31
Start date
2018-04-01
Completion date
2023-12-30
Last updated
2026-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Replacement, Osteoarthritis, Knee

Keywords

CBT

Brief summary

This study seeks to examine multiple risk factors as predictors of pain and function following total knee arthroplasty (TKA). Risk factors will be measured pre-surgically using psychophysical testing procedures, multimodal evaluation of sleep, standardized questionnaires. Additionally, this study will collect pilot data on a brief mindfulness-based cognitive-behavioral treatment that may help to improve long-term TKA outcomes. The pilot study compared TKA patients that received brief mindfulness-based cognitive behavioral therapy (MBCBT) to the treatment-as-usual (TAU) group from the parent study.

Detailed description

The present study seeks to collect pilot data on a brief mindfulness-based cognitive-behavioral treatment to determine the feasibility of this intervention and its potential benefits. The study includes 6 total contacts, 1 visit before surgery and 3 after surgery, and 2 phone calls. The last visit will be about 6 months after surgery. The study includes evaluation of peoples' pain, physical functioning, medication use, and physiological responses to sensory stimuli such as heat and cold. The research takes place at the Brigham & Women's Pain Management Center, 850 Boylston St, Chestnut Hill.

Interventions

BEHAVIORALMindfulness-based Cognitive Behavioral Therapy

Mindfulness-based CBT methods are based on pain self-management paradigms, and involve the identification and reduction of maladaptive pain-related cognitions (i.e., catastrophizing), the enhancement of self-efficacy for managing pain, and training in the use of adaptive pain-coping strategies such as relaxation, distraction, and self-talk.

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

All participants will undergo quantitative sensory testing, physical functioning testing, and pain-related outcomes assessment. Participants in the intervention arm will undergo brief mindfulness-based cognitive behavioral sessions.

Eligibility

Sex/Gender
ALL
Age
45 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. Age 45 or older, 2. Meet the American College of Rheumatology criteria for knee OA, 3. Scheduled to undergo total knee arthroplasty, 4. Facility with the English language that is adequate to complete study procedures

Exclusion criteria

1. Cognitive impairment preventing completion of study assessment procedures. 2. Myocardial infarction within the past 12 months. 3. Presence of Severe Raynaud's or severe neuropathy, 4. Active vasculitis or severe peripheral vascular disease, 5. Current infection, 6. Use of oral steroids, 7. Recent history of substance abuse or dependence, 8. Known anemia

Design outcomes

Primary

MeasureTime frameDescription
Brief Pain Inventory (BPI)baselineMeasure of pain severity and pain interference

Secondary

MeasureTime frameDescription
Quantitative Sensory Testing (QST)baselineMeasures of responses to standardized stimuli
Pain Catastrophizing ScalebaselineAssess catastrophic thinking related to pain
PROMIS-SFbaselineMeasures anxiety and depression symptoms
The Western Ontario McMaster Universities Osteoarthritis Scale (WOMAC)baseline24 items and is a well-validated, widely-used outcomes measure that yields three indices specific to osteoarthritis: 1) pain, 2) disability and 3) joint stiffness, which are sensitive to treatment, with internal consistency coefficients for all scales above 0.8.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRobert Edwards, PhD

Brigham and Women's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 21, 2026